Page 130 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 5 Paraneoplastic Syndromes 109

59. Battaglia L, Petterino C, Zappulli V, et al.: Hypoglycaemia as a 83. Childress MO: Hematologic abnormalities in the small animal
paraneoplastic syndrome associated with renal adenocarcinoma in cancer patient, Vet Clin North Am Small Anim Pract 42:123–155,
a dog, Vet Res Commun 29:671–675, 2005. 2012.
VetBooks.ir 60. Snead EC: A case of bilateral renal lymphosarcoma with second- 84. Peterson EN, Meininger AC: Immunoglobulin A and immuno-
ary polycythaemia and paraneoplastic syndromes of hypoglycaemia
globulin G biclonal gammopathy in a dog with multiple myeloma,
and uveitis in an English Springer Spaniel, Vet Comp Oncol 3:139–
J Am Anim Hosp Assoc 33:45–47, 1997.
144, 2005. 85. Ramaiah SK, Seguin MA, Carwile HF, et al.: Biclonal gammopa-
61. Zapf J: Role of insulin-like growth factor (IGF) II and IGF binding thy associated with immunoglobulin A in a dog with multiple
proteins in extrapancreatic tumour hypoglycaemia, J Intern Med myeloma, Vet Clin Pathol 31:83–89, 2002.
234:543–552, 1993. 86. Grauer GF: Proteinuria: measurement and interpretation, Top
62. Sanpera N, Masot M, Janer C, et al.: Oestrogen-induced bone mar- Companion Anim Med 26:121–127, 2011.
row aplasia in a dog with a Sertoli cell tumour, J Small Anim Pract 87. Cowgill ES, Neel JA, Ruslander D: Light-chain myeloma in a dog,
43:365–369, 2002. J Vet Intern Med 18:119–121, 2004.
63. Sherdig RG, Wildon GP, Kociba GK: Bone marrow hypoplasia 88. Hammer AS, Couto CG: Complications of multiple myeloma,
in eight dogs with Sertoli cell tumor, J Am Vet Med Assoc 178: J Am Anim Hosp Assoc 30:9–14, 1994.
497–501, 1981. 89. Forrester SD, Greco DS, Relford RL: Serum hyperviscosity syn-
64. Weaver AD: Survey with follow-up of 67 dogs with testicular Ser- drome associated with multiple myeloma in two cats, J Am Vet Med
toli cell tumours, Vet Rec 113:105–107, 1983. Assoc 200:79–82, 1992.
65. Reif JS, Brodey RS: The relationship between cryptorchidism and 90. Nitsche EK: Erythrocytosis in dogs and cats: diagnosis and man-
canine testicular neoplasia, J Am Vet Med Assoc 155:2005–2010, 1969. agement, Compend Cont Ed Small Anim Pract 26:104–118, 2004.
66. Kim O, Kim KS: Seminoma with hyperestrogenemia in a Yorkshire 91. Gentilini F, Calzolari C, Buonacucina A, et al.: Different biologic
terrier, J Vet Med Sci 67:121–123, 2005. behavior of waldenstrӧm macroglobulinemia in two dogs, Vet
67. Suess RP, Barr SC, Sacre BJ, et al.: Bone marrow hypoplasia in a Comp Oncol 3:87–97, 2005.
feminized dog with an interstitial cell tumor, J Am Vet Med Assoc 92. Hendrix DV, Gelatt KN, Smith PJ, et al.: Ophthalmic disease as
200:1346–1348, 1992. a presenting complaint in five dogs with multiple myeloma, J Am
68. McCandlish IA, Munro C, Breeze RG, et al.: Hormone producing Anim Hosp Assoc 34:121–128, 1998.
ovarian tumours in the dog, Vet Rec 105:9–11, 1979. 93. Boyle TE, Holowaychuk MK, Adams AK, et al.: Treatment of three
69. Mischke R, Meurer D, Hoppen HO, et al.: Blood plasma concen- cats with hyperviscosity syndrome and congestive heart failure
trations of oestradiol-17β, testosterone, and testosterone/estradiol using plasmapheresis, J Am Anim Hosp Assoc 47:50–55, 2011.
ratio in dogs with neoplastic and degenerative testicular diseases, 94. Bartages JW: Therapeutic plasmapheresis, Semin Vet Med Surg
Res Vet Sci 73:267–272, 2002. (Small Anim) 12:170–177, 1997.
70. Peters MA, Mol JA, van Wolferen ME, et al.: Expression of insu- 95. Abbo AH, Lucroy MD: Assessment of anemia as an independent
lin-like growth factor (IGF) system and steroidogenic enzymes in predictor of response to chemotherapy and survival in dogs with
canine testis tumors, Reprod Biol Endocrinol 1:22–29, 2003. lymphoma, J Am Vet Med Assoc 231:1836–1842, 2007.
71. Hurty CA, Flatland B: Feline acromegaly, a review of the syndrome, 96. Miller AG, Morley PS, Rao S, et al.: Anemia is associated with
J Am Anim Hosp Assoc 41:292–297, 2005. decreased survival time in dogs with lymphoma, J Vet Intern Med
72. Peterson ME, Taylor RS, Greco DS, et al.: Acromegaly in 14 cats, 23:116–122, 2009.
J Vet Intern Med 4:192–201, 1990. 97. Haney SM, Beaver L, Turrel J, et al.: Survival analysis of 97 cats
73. Niessen SJ, Church DB, Forcada Y: Hypersomatropism, acromeg- with nasal lymphoma: a multi-institutional retrospective study
aly, and hyperadrenocortcism and feline diabetes mellitus, Vet Clin (1986–2006), J Vet Intern Med 23:287–294, 2009.
North Am Small Anim Pract 43:221–231, 2013. 98. Pintar J, Breitschwerdt EB, Hardie EM, et al.: Acute nontraumatic
74. vanKeulen LJ, Wesdorp JL, Kooistra HS: Diabetes mellitus in a hemoabdomen in the dog: a retrospective analysis of 39 cases
dog with a growth hormone-producing acidophilic adenoma of the (1987–2001), J Am Anim Hosp Assoc 39, 2003. 528–522.
adenohypophysis, Vet Pathol 33:451–453, 1996. 99. Aronsohn MG, Dubiel B, Roberts B, et al.: Prognosis for acute
75. Murai A, Nishii N, Morita T, et al.: GH-producing mammary nontraumatic hemoperitoneum in the dog: a retrospective analysis
tumors in two dogs with acromegaly, J Vet Med Sci 74:771–774, of 60 cases (2003–2006), J Am Anim Hosp Assoc 45:72–77, 2009.
2012. 100. Whittemore JC, Preston CA, Kyles AE, et al.: Nontraumatic rup-
76. Ogilvie GK, Weigel RM, Haschek WM, et al.: Prognostic factors ture of an adrenal gland tumor causing intra-abdominal or ret-
for tumor remission and survival in dogs after surgery for primary roperitoneal hemorrhage in four dogs, J Am Vet Med Assoc 219:
lung tumor: 76 cases (1975–1985), J Am Vet Med Assoc 195:109– 329–333, 2001.
112, 1989. 101. Slensky KA, Volk SW, Schwarz T, et al.: Acute severe hemorrhage
77. Galac S, Kooistra HS, Voorhout G, et al.: Hyperadrenocorticism secondary to arterial invasion in a dog with thyroid carcinoma,
in a dog due to ectopic secretion of adrenocorticotropic hormone, J Am Vet Med Assoc 223:649–653, 2003.
Domest Anim Endocrinol 28:338–348, 2005. 102. Hohenhaus AE, Winzelberg SE: Nonregenerative anemia. In
78. Churcher RK: Hepatic carcinoid, hypercortisolism, and hypokalae- Ettinger SJ, Feldman EC, Côté, editors: Textbook of veterinary inter-
mia in a dog, Aust Vet J 77:641–645, 1999. nal medicine, ed 8, St. Louis, 2017, Elsevier, pp 829–837.
79. MacEwen GE, Hurvitz A: Diagnosis and management of monoclo- 103. McCullough S: Immune-mediated hemolytic anemia: understand-
nal gammopathies, Vet Clin North Am 7:119–132, 1977. ing the nemesis, Vet Clin North Am Small Anim Pract 33:1295–
80. Mellor PJ, Haugland S, Murphy S, et al.: Myeloma-related disor- 1315, 2003.
ders in cats commonly present as extramedullary neoplasms in con- 104. Madewell BR, Feldman BF: Characterization of anemias asso-
trast to myeloma in human patient: 24 cases with clinical follow up, ciated with neoplasia in small animals, J Am Vet Med Assoc 176:
J Vet Intern Med 20:1376–1383, 2006. 419–425, 1980.
81. Giraudel JM, Pagѐs JP, Fuilfi JF: Monoclonal gammopathies in the 105. Hammer AS, Couto CG, Swardson C, et al.: Hemostatic abnor-
dog: a retrospective study of 18 cases (1986–1999) and literature malities in dogs with hemangiosarcoma, J Vet Intern Med 5:
review, J Am Anim Hosp Assoc 39:135–147, 2002. 11–14, 1991.
82. Rout ED, Shank AM, Waite AH, et al.: Progression of cutaneous 106. Moore PF, Affolter VK, Vernau W: Canine hemophagocytic histio-
plasmacytoma to plasma cell leukemia in a dog, Vet Clin Pathol cytic sarcoma: a proliferative disorder of CD11+ macrophages, Vet
46:77–84, 2017. Pathol 43:632–645, 2006.